SAN DIEGO--(BUSINESS WIRE)--Sept. 20, 2006--Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, today announced that Gerald T. Proehl, president and chief executive officer, will make a presentation to the investment community at the UBS Global Life Sciences Conference on Wednesday, September 27, 2006 at 10:00 a.m. Eastern time (7:00 a.m. Pacific time) at the Grand Hyatt Hotel in New York City.
